Learning Center

8 December 2020

Centering on the Patient by Decentralizing Clinical Trials

Marken President Ariette Van Strien addresses whether the momentum toward decentralized trials will continue after the pandemic

As an industry, each and every one of us plays a part in ensuring that decentralized trials continue to take hold and find increasing traction and success,” she says. “The question of whether or not the momentum can be maintained post-COVID-19 simply isn’t a question or an option. It’s an imperative.

You can rely on us when it comes to decentralizing clinical trials because we are a wholly owned subsidiary of UPS and the essential clinical part of UPS Healthcare. With Marken, BOMI Group, and Polar Speed included, the UPS Healthcare network staffs 199 locations with 10,000+ employees worldwide.

Marken Logo

Understanding why we must adapt, continuously asking ourselves how we can change what matters is how we keep on delivering it.